Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.
暂无分享，去创建一个
Lyanne M. Kieneker | R. D. de Boer | G. Navis | H. Hillege | S. Bakker | R. Gansevoort | R. Stolk | J. Struck | A. Abbasi | R. Gans | E. Corpeleijn | L. Kieneker